Get started
Author

Hina Qayoom

ORCID: 0000-0001-8484-3424
Observed ORCID: 0000-0001-8484-3424
OpenAlex ID: A5027748773
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
2022 · Shazia Sofi, Umar Mehraj, et al. · Medical Oncology · 125
PDF
Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer
2020 · Manzoor A. Mir, Hina Qayoom, et al. · Current Cancer Drug Targets · 119
An Insight Into the Cancer Stem Cell Survival Pathways Involved in Chemoresistance in Triple-Negative Breast Cancer
2021 · Hina Qayoom, Nissar A Wani, et al. · Future Oncology · 101
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications
2022 · Shazia Sofi, Umar Mehraj, et al. · Medical Oncology · 97
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives
2021 · Umar Mehraj, Hina Qayoom, et al. · Breast Cancer · 82
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis
2023 · Hina Qayoom, Shazia Sofi, et al. · Immunologic Research · 77
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
2024 · Hina Qayoom, Burhan Ul Haq, et al. · Cell Communication and Signaling · 76
PDF
Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
2024 · Nusrat Jan, Shazia Sofi, et al. · Heliyon · 73
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
2023 · Shazia sofi, Nusrat Jan, et al. · Saudi Journal of Biological Sciences · 68
Targeting breast cancer stem cells through retinoids: A new hope for treatment
2023 · Nusrat Jan, Shazia Sofi, et al. · Critical Reviews in Oncology/Hematology · 62
A comprehensive analysis of notch signaling genes in breast cancer: Expression pattern and prognostic significance
2023 · Shazia Sofi, Hina Qayoom, et al. · Advances in Cancer Biology - Metastasis · 52
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis
2024 · Burhan Ul Haq, Hina Qayoom, et al. · Frontiers in Pharmacology · 47
PDF
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
2023 · Hina Qayoom, Mustfa Alkhanani, et al. · Medical Oncology · 40
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study
2022 · Hina Qayoom, Umar Mehraj, et al. · Medical Oncology · 34
Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells -An In vitroandIn silicoStudy
2022 · Umar Mehraj, Hina Qayoom, et al. · Anti-Cancer Agents in Medicinal Chemistry · 34
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
2023 · Hina Qayoom, Mustfa Alkhanani, et al. · Saudi Journal of Biological Sciences · 30
Integrating Immunotherapy with Chemotherapy: A New Approach to Drug Repurposing
2021 · Hina Qayoom, Umar Mehraj, et al. · IntechOpen eBooks · 26
Proteomics: Application of next-generation proteomics in cancer research
2023 · Manzoor Ahmad Mir, Hina Qayoom, et al. · Elsevier eBooks · 23
Proteomics: A groundbreaking development in cancer biology
2023 · Manzoor Ahmad Mir, Hina Qayoom, et al. · Elsevier eBooks · 22
Mutant P53 modulation by cryptolepine through cell cycle arrest and apoptosis in triple negative breast cancer
2024 · Hina Qayoom, Manzoor A. Mir · Biomedicine & Pharmacotherapy · 18
Decoding the molecular mechanism of stypoldione against breast cancer through network pharmacology and experimental validation
2023 · Hina Qayoom, Bader Alshehri, et al. · Saudi Journal of Biological Sciences · 17
Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors
2024 · Aisha Shabir, Hina Qayoom, et al. · Frontiers in Pharmacology · 16
PDF
Therapeutic Options for Breast Cancer
2021 · Shariqa Aisha, Hina Qayoom, et al. · Nova Science Publishers eBooks · 14
Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis
2024 · Hina Qayoom, Sania Bashir, et al. · Computational Biology and Chemistry · 13
Conventional Chemotherapy vs. Metronomic Chemotherapy
2024 · Manzoor Ahmad Mir, Nusrat Jan, et al. · CRC Press eBooks · 13
Works count: 53
Citation count: 1,383
H-index: 19
I10-index: 30
Year
Topic
Type